Log In
Print this Print this

Factor V concentrate

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionFactor V concentrate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsTreat rare bleeding disorders
Regulatory Designation EU - Orphan Drug (Treat rare bleeding disorders)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today